Maulana, Basir W.

HRN: 25-23-86  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2024
CEFTAZIDIME 1GM (VIAL)
05/31/2024
06/07/2024
IVTT
1 Gram
Q8H
CAP MR
Waiting Final Action 
05/31/2024
AZITHROMYCIN 500MG TABLET (TAB)
05/31/2024
06/05/2024
PO
500mg
OD
CAP-MR
Waiting Final Action 
06/12/2025
CEFTAZIDIME 1GM (VIAL)
06/12/2025
06/19/2025
IV
2g
Q24
Pulmonary Fibrosis To R/o PTB Retreatment After Lost To Follow Up
Remove - Pending Acceptance
06/13/2025
CEFTAZIDIME 1GM (VIAL)
06/13/2025
06/20/2025
IV
1g
Q8h
Pulmonary Fibrosis R/o PTB Retreatment After Lost To Followup
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: